Cooper Companies, Inc. COO
We take great care to ensure that the data presented and summarized in this overview for COOPER COMPANIES, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding COO
View all-
Intermede Investment Partners LTD917KShares$66.2 Million2.58% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8143KShares$10.3 Million0.07% of portfolio
-
Crystal Rock Capital Management86.2KShares$6.22 Million3.49% of portfolio
-
Eaton Vance Management Boston, MA86.1KShares$6.21 Million0.03% of portfolio
-
Brant Point Investment Management LLC New York, NY78.1KShares$5.63 Million0.62% of portfolio
-
Cibc World Markets Corp New York, NY25.2KShares$1.82 Million0.01% of portfolio
-
Polaris Wealth Advisory Group, LLC5.83KShares$420,6620.14% of portfolio
-
Ferguson Wellman Capital Management, Inc3.34KShares$240,9140.0% of portfolio
-
Allstate Investment Management CO Northbrook, IL3.03KShares$218,5530.03% of portfolio
-
Laurel Wealth Advisors, Inc. Solana Beach, CA2.58KShares$186,1670.08% of portfolio
Latest Institutional Activity in COO
Top Purchases
Top Sells
About COO
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Insider Transactions at COO
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 12
2026
|
Colleen Jay |
BUY
Exercise of conversion of derivative security
|
Direct |
7,064
+16.18%
|
$275,496
$39.4 P/Share
|
|
Jan 08
2026
|
Albert G White Iii President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,419
-3.7%
|
$781,777
$83.13 P/Share
|
|
Jan 08
2026
|
Albert G White Iii President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,340
+6.72%
|
-
|
|
Jan 08
2026
|
Brian G Andrews EVP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,893
-18.15%
|
$157,119
$83.13 P/Share
|
|
Jan 08
2026
|
Brian G Andrews EVP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,528
+25.28%
|
-
|
|
Jan 08
2026
|
Daniel G Mc Bride EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,655
-3.01%
|
$552,365
$83.13 P/Share
|
|
Jan 08
2026
|
Daniel G Mc Bride EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,887
+5.66%
|
-
|
|
Jan 08
2026
|
Holly R Sheffield President, CSI |
SELL
Payment of exercise price or tax liability
|
Direct |
3,841
-2.79%
|
$318,803
$83.13 P/Share
|
|
Jan 08
2026
|
Holly R Sheffield President, CSI |
BUY
Exercise of conversion of derivative security
|
Direct |
8,050
+5.67%
|
-
|
|
Jan 08
2026
|
Gerard H Warner Iii President, CooperVision, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
5,985
-4.37%
|
$496,755
$83.13 P/Share
|
|
Jan 08
2026
|
Gerard H Warner Iii President, CooperVision, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
11,518
+8.35%
|
-
|
|
Dec 22
2025
|
Cynthia L Lucchese |
BUY
Open market or private purchase
|
Direct |
1,784
+15.89%
|
$149,856
$84.06 P/Share
|
|
Dec 18
2025
|
Maria Rivas |
BUY
Open market or private purchase
|
Indirect |
1,000
+8.24%
|
$82,000
$82.13 P/Share
|
|
Dec 17
2025
|
Lawrence Erik Kurzius |
BUY
Open market or private purchase
|
Direct |
2,000
+20.46%
|
$164,000
$82.5 P/Share
|
|
Dec 16
2025
|
Albert G White Iii President & CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+4.06%
|
$800,000
$80.8 P/Share
|
|
Dec 16
2025
|
Holly R Sheffield President, CSI |
BUY
Open market or private purchase
|
Direct |
1,230
+3.05%
|
$98,400
$80.75 P/Share
|
|
Dec 12
2025
|
Robert S Weiss |
SELL
Bona fide gift
|
Indirect |
7,500
-2.83%
|
-
|
|
Sep 29
2025
|
Lawrence Erik Kurzius |
BUY
Open market or private purchase
|
Direct |
2,000
+25.72%
|
$136,000
$68.39 P/Share
|
|
Sep 05
2025
|
Albert G White Iii President & CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+4.23%
|
$680,000
$68.39 P/Share
|
|
Sep 05
2025
|
Gerard H Warner Iii President, CooperVision, Inc. |
BUY
Open market or private purchase
|
Direct |
1,450
+7.33%
|
$100,050
$69.23 P/Share
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 224K shares |
|---|---|
| Open market or private purchase | 34K shares |
| Payment of exercise price or tax liability | 99.8K shares |
|---|---|
| Bona fide gift | 7.5K shares |